Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
9 June 2017
E-003872-17
Question for written answer
to the Commission
Rule 130
José Inácio Faria (PPE)

 Subject:  Safer healthcare in Europe: improving patient safety and fighting antimicrobial resistance
 Answer(s) 

Parliament’s resolution of 19 May 2015 on safer healthcare in Europe: improving patient safety and fighting antimicrobial resistance incorporates a number of significant amendments.

These are reflected in the following paragraphs: ‘Urges the Member States to implement or develop the following measures: […] ensure that medical professionals inform patients when a medicine is used off-label and provide patients with information on the potential risks in order to enable them to give informed consent; […] Calls on Member States to investigate possible malpractice involved in the refurbishment and re-use of medical devices originally designed and labelled for single use; […] Calls on the European Medicines Agency (EMA) to develop guidelines on the off-label/unlicensed use of medicines based on medical need, as well as to compile a list of off-label medicines in use despite licensed alternatives; […] Calls on the Commission and the Member States to promote the introduction of the European logo provided for by Implementing Regulation (EU) No 699/2014 in order to identify clearly online pharmacies which offer medicines for sale to the public remotely while safeguarding consumers against the purchase of fake medicines, which are often a health hazard […]’.

Can the Commission say what progress has been made in addressing these important amendments?

Last updated: 26 June 2017Legal notice